AllianceBernstein’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-72,228
| Closed | -$809K | – | 3131 |
|
2017
Q3 | $809K | Sell |
72,228
-162,500
| -69% | -$1.82M | ﹤0.01% | 2368 |
|
2017
Q2 | $2.58M | Buy |
234,728
+46,680
| +25% | +$513K | ﹤0.01% | 1637 |
|
2017
Q1 | $1.84M | Sell |
188,048
-131,950
| -41% | -$1.29M | ﹤0.01% | 1862 |
|
2016
Q4 | $3.46M | Buy |
319,998
+1,890
| +0.6% | +$20.4K | ﹤0.01% | 1411 |
|
2016
Q3 | $3.26M | Buy |
318,108
+158,070
| +99% | +$1.62M | ﹤0.01% | 1398 |
|
2016
Q2 | $2.09M | Buy |
160,038
+21,540
| +16% | +$281K | ﹤0.01% | 1664 |
|
2016
Q1 | $1.52M | Buy |
138,498
+53,190
| +62% | +$585K | ﹤0.01% | 1818 |
|
2015
Q4 | $785K | Sell |
85,308
-1,220
| -1% | -$11.2K | ﹤0.01% | 2245 |
|
2015
Q3 | $601K | Sell |
86,528
-200
| -0.2% | -$1.39K | ﹤0.01% | 2410 |
|
2015
Q2 | $852K | Hold |
86,728
| – | – | ﹤0.01% | 2354 |
|
2015
Q1 | $768K | Hold |
86,728
| – | – | ﹤0.01% | 2310 |
|
2014
Q4 | $760K | Sell |
86,728
-12,000
| -12% | -$105K | ﹤0.01% | 2336 |
|
2014
Q3 | $680K | Sell |
98,728
-3,100
| -3% | -$21.4K | ﹤0.01% | 2391 |
|
2014
Q2 | $536K | Sell |
101,828
-949
| -0.9% | -$5K | ﹤0.01% | 2488 |
|
2014
Q1 | $468K | Sell |
102,777
-4,333
| -4% | -$19.7K | ﹤0.01% | 2449 |
|
2013
Q4 | $540K | Sell |
107,110
-6,518
| -6% | -$32.9K | ﹤0.01% | 2397 |
|
2013
Q3 | $576K | Sell |
113,628
-1,747
| -2% | -$8.86K | ﹤0.01% | 2389 |
|
2013
Q2 | $572K | Buy |
+115,375
| New | +$572K | ﹤0.01% | 2398 |
|